Fairchem Organics Limited

NSE:FAIRCHEMOR.NS

988.5 (INR) • At close January 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q3
Revenue 1,386.1861,649.2831,515.081,476.5341,518.7771,603.4951,515.0771,022.2911,682.5852,249.4171,773.6981,582.7191,676.6171,389.7641,590.9351,068.293948.555350.118891.636801.359
Cost of Revenue 1,052.2631,359.9071,159.061,069.8511,139.0211,267.6771,104.084815.5151,362.8431,624.7021,436.481,154.4281,155.889900.4091,166.86716.507597.612244.683603.691550.16
Gross Profit 333.923289.376356.02406.683379.756335.818410.993206.776319.742624.715337.218428.291520.728489.355424.075351.786350.943105.435287.945251.199
Gross Profit Ratio 0.2410.1750.2350.2750.250.2090.2710.2020.190.2780.190.2710.3110.3520.2670.3290.370.3010.3230.313
Reseach & Development Expenses 001.6260001.9480001.9390001.539000.4222.5980
General & Administrative Expenses 00174.55200072.21100043.57800067.393004.08234.6190
Selling & Marketing Expenses 002.4280002.5970003.5350001.948006.9141.1520
SG&A 097.456176.9871.77378.05551.64174.80860.6173.20248.65547.11345.06644.21455.14769.34137.9848.93110.99635.77134.89
Other Expenses 333.92302.8132.4524.5511.5231.6882.7190.0332.837-2.840.9130.3654.058-0.1690.0730.1070.006-63.7491.366
Operating Expenses 333.92397.456184.51233.157233.121241.075239.923190.891247.135243.005167.704233.271220.678177.737164.967155.729213.25294.26197.612148.93
Operating Income 61.148191.92171.51175.978151.18694.743359.57318.60472.64381.71169.514195.02300.05311.618277.01196.057137.79813.639211.35102.269
Operating Income Ratio 0.0440.1160.1130.1190.10.0590.2370.0180.0430.170.0960.1230.1790.2240.1740.1840.1450.0390.2370.128
Total Other Income Expenses Net -6.393-5.754-3.361-7.208-8.482-12.003-199.995-6.5-16.134-21.221-17.249-14.397-19.864-12.288-18.97-16.014-15.516-14.857-23.34-15.733
Income Before Tax 54.755186.166159.58166.318138.15382.74159.5789.38556.473360.489152.265180.623280.186299.33240.138180.043122.175-3.683166.99386.536
Income Before Tax Ratio 0.040.1130.1050.1130.0910.0520.1050.0090.0340.160.0860.1140.1670.2150.1510.1690.129-0.0110.1870.108
Income Tax Expense 14.64947.64440.9743.0135.29721.51440.9743.29916.44390.19439.83346.08571.21276.2151.83946.01331.6-1.78536.26621.216
Net Income 40.106138.522117.613123.308102.85661.226118.6046.08640.03270.295112.432134.538208.974223.12188.299134.0390.575-1.898130.72765.32
Net Income Ratio 0.0290.0840.0780.0840.0680.0380.0780.0060.0240.120.0630.0850.1250.1610.1180.1250.095-0.0050.1470.082
EPS 3.0810.649.119.477.94.79.110.473.0720.768.6310.3316.0517.1414.4610.296.96-0.1510.075.03
EPS Diluted 3.0810.649.119.477.94.79.110.473.0720.768.6310.3316.0517.1414.4610.296.96-0.1510.075.03
EBITDA 91.351220.145187.611199.961172.944117.808194.03439.46693.142403.426187.485214.096318.06332.628277.865212.755160.00127.433200.933119.684
EBITDA Ratio 0.0660.1330.1240.1350.1140.0730.1140.0790.0550.1790.1060.1350.190.2390.1750.1990.1630.0790.2250.149